Impact BioMedical, INC. (IBO) ROA
- 2026-06-30: ROA 4.71%.
- 2026-03-31: ROA -75.25%.
- 2025-12-31: ROA -68.01%.
- 2025-09-30: ROA -242.70%.
Complete source-backed roa history.
- Available history
- 2022-12-31 to 2026-06-30
- Data captured
Historical ROA
| Date | ROA |
|---|---|
| 2026-06-30 | 4.71% |
| 2026-03-31 | -75.25% |
| 2025-12-31 | -68.01% |
| 2025-09-30 | -242.70% |
| 2025-06-30 | -201.86% |
| 2025-03-31 | -124.77% |
| 2024-12-31 | -121.79% |
| 2024-09-30 | 2.58% |
| 2024-06-30 | -9.56% |
| 2024-03-31 | -10.03% |
| 2023-12-31 | -9.72% |
| 2023-09-30 | -14.45% |
| 2023-06-30 | -16.46% |
Annual ROA
| Date | ROA |
|---|---|
| 2025-12-31 | -68.01% |
| 2024-12-31 | -121.77% |
| 2023-12-31 | -9.71% |
| 2022-12-31 | -15.60% |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |